<DOC>
	<DOCNO>NCT00142818</DOCNO>
	<brief_summary>Modafinil medication may enhance mood increase energy cocaine addict , may useful prevent cocaine relapse . Naltrexone medication currently use treat drug alcohol addiction . A combination two medication may beneficial reduce drug alcohol use individual undergo substance abuse treatment . The purpose study evaluate effectiveness modafinil naltrexone , alone combination , reduce drug alcohol use individual addict cocaine alcohol .</brief_summary>
	<brief_title>Modafinil Naltrexone Reduce Cocaine Alcohol Dependence</brief_title>
	<detailed_description>Cocaine alcohol addiction serious health problem available medical treatment prevent relapse . Past research show individual addict cocaine alcohol typically respond poorly conventional substance abuse treatment . Little attention direct towards best treat individual . Naltrexone medication currently use treat drug alcohol addiction . It act block `` high '' feeling produce drug alcohol . Modafinil , another medication , enhance mood , increase energy , improve concentration people narcolepsy . Preliminary research show may produce similar effect cocaine , thereby potentially counter symptom cocaine withdrawal . Cognitive Behavioral Coping Skills Therapy ( CBT ) , form therapy aim alter individual 's pattern behavior drug use , also important component substance abuse treatment . The purpose study compare effectiveness CBT plus placebo , CBT plus modafinil , CBT plus naltrexone , CBT plus combination modafinil naltrexone reduce cocaine alcohol use individual addict substance . This 14-week study enroll individual addict cocaine alcohol . During 1-week screening period , potential participant require complete detoxification program , include stop cocaine alcohol use . Participants also undergo physical exam electrocardiogram . Blood drawn laboratory test , urine test use screen presence drug alcohol . Individuals complete screen meet study requirement permit participate treatment phase study . During 13-week treatment phase , participant randomly assign receive modafinil , naltrexone , combination modafinil naltrexone , placebo . All participant attend CBT session week . Study visit take place twice week . At visit , urine test breathalyzer use screen presence alcohol drug . Participants also complete standardized psychological questionnaire measure drug alcohol craving , treatment service receive , severity illness , withdrawal symptom . In addition , participant meet weekly nurse practitioner , dispense study medication , monitor adverse event , evaluate participant 's clinical status . A follow-up evaluation occur 6 month follow end treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>4.1 Inclusion Criteria 1 . Male female , 18 year age old . 2 . Meets DSMIV criterion current diagnosis cocaine alcohol dependence , determine SCIDIV . 3 . In past 30 day , use less $ 200worth cocaine meet follow drinking criterion measure Timeline Followback ( TLFB ) ( Sobell , 1995 ) : 1. drank within 30 day intake day , 2. report minimum 48 standard alcoholic ( avg . 12 drinks/wk ) consecutive 30day period 90day period prior start intake ( i.e. , minimum 40 % day drinking ) , 3. 2 day heavy drinking ( defined 5 drink per day male 4 drink per day female ) pretreatment period . 4 . 72 consecutive hour abstinence alcohol , determine selfreports confirm negative breathalyzer test , Clinical Institute Withdrawal Scale Alcohol ( CIWAAR ) ( Sullivan , 1989 ) score eight . Subjects encourage achieve 72 consecutive hour abstinence , however , subject achieve 48 72 consecutive hour abstinence include approval principal investigator . We anticipate subject comprise less 5 % total enrolled subject . Subjects give 2 additional week beyond screen week attain appropriate period alcohol abstinence prior randomization . 5 . Lives commutable distance TRC agree attend research visit include followup visit . 6 . Speaks , understand , print English 7 . Ability give inform consent Exclusion Criteria 1 . Abstinent cocaine alcohol 30 consecutive day prior sign consent form . 2 . Meets DSM IV criterion dependence substance cocaine alcohol ( except nicotine ) , determine SCID . 3 . Needs treatment psychoactive medication include antiseizure medication ( exception diphenhydramine use sparingly , necessary , sleep ) . 4 . Meets current lifetime DSMIV criterion schizophrenia psychotic disorder organic mental disorder . Subject meet current DSMIV diagnosis clinically significant psychiatric disorder interfere study participation . 5 . Has evidence history significant hematological , pulmonary , endocrine , cardiovascular , renal gastrointestinal disease ( include history myocardial infarction , mitral valve prolapse , leave ventricular hypertrophy , uncontrolled hypertension ) . 6 . Severe physical medical illness AIDS , active hepatitis , significant hepatocellular injury evidence elevated total bilirubin level ( &gt; 1.3 mg/dl ) , elevate level ( 4.5x normal ) aspartate aminotransferase ( AST ) , serum glutamicpyruvic transaminase ( SGPT ) require 3 day abstinence . 7 . Use investigational medication 30 day prior randomization . 8 . History hypersensitivity modafinil naltrexone 9 . Receiving chronic therapy drug know interact adversely either modafinil naltrexone include propranolol , phenytoin , warfarin , diazepam 10 . Took monoamine oxidase inhibitor within 30 day randomization . 11 . Is female test positive pregnancy test , contemplate pregnancy next 6 month , nursing , use effective contraceptive method ( relevant ) . Acceptable method contraception include barrier method ( diaphragm condom spermicide , female condom ) , intrauterine progesterone contraceptive system , levonorgrestrel implant , medroxyprogeterone acetate contraceptive injection , copper IUD , vaginal contraceptive film , cervical cap , contraceptive foam . 12 . Current use oral contraceptive without acceptable barrier method contraception . 13 . Received therapy opiate substitute ( methadone , LAAM , buprenorphine ) within 60 day randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Alcohol Abuse</keyword>
	<keyword>Cocaine Abuse</keyword>
</DOC>